BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28325748)

  • 1. Halogenated Ether, Alcohol, and Alkane Anesthetics Activate TASK-3 Tandem Pore Potassium Channels Likely through a Common Mechanism.
    Luethy A; Boghosian JD; Srikantha R; Cotten JF
    Mol Pharmacol; 2017 Jun; 91(6):620-629. PubMed ID: 28325748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent modification of a volatile anesthetic regulatory site activates TASK-3 (KCNK9) tandem-pore potassium channels.
    Conway KE; Cotten JF
    Mol Pharmacol; 2012 Mar; 81(3):393-400. PubMed ID: 22147752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.
    Chokshi RH; Larsen AT; Bhayana B; Cotten JF
    Mol Pharmacol; 2015 Nov; 88(5):926-34. PubMed ID: 26268529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of volatile and intravenous anesthetics on the activity of human TASK-1.
    Putzke C; Hanley PJ; Schlichthörl G; Preisig-Müller R; Rinné S; Anetseder M; Eckenhoff R; Berkowitz C; Vassiliou T; Wulf H; Eberhart L
    Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1319-26. PubMed ID: 17699638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of halogenated inhaled anesthetics on voltage-gated Na+ channel function.
    Ouyang W; Herold KF; Hemmings HC
    Anesthesiology; 2009 Mar; 110(3):582-90. PubMed ID: 19225394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalational anesthetics activate two-pore-domain background K+ channels.
    Patel AJ; Honoré E; Lesage F; Fink M; Romey G; Lazdunski M
    Nat Neurosci; 1999 May; 2(5):422-6. PubMed ID: 10321245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ventilatory stimulant doxapram inhibits TASK tandem pore (K2P) potassium channel function but does not affect minimum alveolar anesthetic concentration.
    Cotten JF; Keshavaprasad B; Laster MJ; Eger EI; Yost CS
    Anesth Analg; 2006 Mar; 102(3):779-85. PubMed ID: 16492828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrokinetic analysis of blockade of NMDA-gated currents by substituted alcohols, alkanes and ethers.
    Criswell HE; Ming Z; Pleasant N; Griffith BL; Mueller RA; Breese GR
    Brain Res; 2004 Jul; 1015(1-2):107-13. PubMed ID: 15223373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motoneuronal TASK channels contribute to immobilizing effects of inhalational general anesthetics.
    Lazarenko RM; Willcox SC; Shu S; Berg AP; Jevtovic-Todorovic V; Talley EM; Chen X; Bayliss DA
    J Neurosci; 2010 Jun; 30(22):7691-704. PubMed ID: 20519544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TOK1 is a volatile anesthetic stimulated K+ channel.
    Gray AT; Winegar BD; Leonoudakis DJ; Forsayeth JR; Yost CS
    Anesthesiology; 1998 Apr; 88(4):1076-84. PubMed ID: 9579518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive Interactions between Halothane and Isoflurane at the Carotid Body and TASK Channels.
    Pandit JJ; Huskens N; O'Donohoe PB; Turner PJ; Buckler KJ
    Anesthesiology; 2020 Nov; 133(5):1046-1059. PubMed ID: 32826405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of TASK-1 (Kcnk3) and TASK-3 (Kcnk9) potassium channels: volatile anesthetics and neurotransmitters share a molecular site of action.
    Talley EM; Bayliss DA
    J Biol Chem; 2002 May; 277(20):17733-42. PubMed ID: 11886861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent activation of the human tandem pore domain K channel TRESK with clinical concentrations of volatile anesthetics.
    Liu C; Au JD; Zou HL; Cotten JF; Yost CS
    Anesth Analg; 2004 Dec; 99(6):1715-1722. PubMed ID: 15562060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of KCNK5 or Kir3.2 potassium channels in mice does not change minimum alveolar anesthetic concentration.
    Gerstin KM; Gong DH; Abdallah M; Winegar BD; Eger EI; Gray AT
    Anesth Analg; 2003 May; 96(5):1345-1349. PubMed ID: 12707131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Small-Molecule Compound Selectively Activates K2P Channel TASK-3 by Acting at Two Distant Clusters of Residues.
    Tian F; Qiu Y; Lan X; Li M; Yang H; Gao Z
    Mol Pharmacol; 2019 Jul; 96(1):26-35. PubMed ID: 31015283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Calcium Release Channel (Ryanodine Receptor 2) Regulation by Halogenated Anesthetics.
    Laver DR; Attia J; Oldmeadow C; Quail AW
    Anesthesiology; 2017 Mar; 126(3):495-506. PubMed ID: 28079567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TASK-1 (KCNK3) and TASK-3 (KCNK9) tandem pore potassium channel antagonists stimulate breathing in isoflurane-anesthetized rats.
    Cotten JF
    Anesth Analg; 2013 Apr; 116(4):810-6. PubMed ID: 23460565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vivo contributions of TASK-1-containing channels to the actions of inhalation anesthetics, the alpha(2) adrenergic sedative dexmedetomidine, and cannabinoid agonists.
    Linden AM; Aller MI; Leppä E; Vekovischeva O; Aitta-Aho T; Veale EL; Mathie A; Rosenberg P; Wisden W; Korpi ER
    J Pharmacol Exp Ther; 2006 May; 317(2):615-26. PubMed ID: 16397088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic insights into volatile anesthetic modulation of K2P channels.
    Wague A; Joseph TT; Woll KA; Bu W; Vaidya KA; Bhanu NV; Garcia BA; Nimigean CM; Eckenhoff RG; Riegelhaupt PM
    Elife; 2020 Dec; 9():. PubMed ID: 33345771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel activation of voltage-gated K(+) channels by sevoflurane.
    Barber AF; Liang Q; Covarrubias M
    J Biol Chem; 2012 Nov; 287(48):40425-32. PubMed ID: 23038249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.